CVG Competitors

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

University Health Network (UHN) is Canada's largest research hospital, which includes Toronto General and Toronto Western Hospitals, Princess Margaret Cancer Centre, the Toronto Rehabilitation Institute and the Michener Institute for Education at UHN. The scope of research and complexity of cases at UHN has made it a national and international source for research, education and patient care. UHN is a research hospital affiliated with the University of Toronto, with major research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. The Toronto General & Western Hospital Foundation, The Princess Margaret Cancer Foundation and Toronto Rehab Foundation allow us to fulfill our purpose by engaging our generous donor community and raising critical funds for research, education and improving the experience of our patients. Our Purpose: Transforming lives and communities through excellence in care, discovery and learning. Our Primary Value: The needs of patients come first. Our Values: Safety, compassion, teamwork, integrity and stewardship.

We are Canada’s biological lifeline. We are the connection between the sincere generosity of donors and the heartfelt appreciation of recipients, between the profound discoveries of science and the joyful restoration of health. As such, we are nationally responsible for a secure system of life essentials for transfusion or transplantation that’s reliable, accessible and sustainable. That’s why our organization must be efficient, our performance disciplined. We must work as one with our colleagues and partners at all levels. We must be prudent yet smart, rigorous yet agile, capable yet concerned. And we must be innovative, reinventing today so we can find better answers for tomorrow. In a very real way, what we do affects the well-being of all Canadians and every day we must earn their trust. We make a difference and in that, we take great pride Canadian Blood Services strives to create informative and engaging communities on social media. We ask that users heed our Community Guidelines